# Evaluation of Succinate Metoprolol on Heart Rate in the Stable Angina Patients

Study · id `cardio:ct-nct01213173` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01213173](<https://clinicaltrials.gov/study/NCT01213173>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT01213173

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 251 participants.

## Technical summary

Registry record NCT01213173. Randomized; no masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2011-09 (actual). Results posted on 2013-08-26.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 251 participants (enrolled count; ClinicalTrials.gov record NCT01213173, source copy `cardio:ctgov-nct01213173-2014-09-05`, retrieved 2026-11-18)
- Start date: 2010-10 (registry gives no type) (ClinicalTrials.gov record NCT01213173, source copy `cardio:ctgov-nct01213173-2014-09-05`, retrieved 2026-11-18)
- Primary completion: 2011-09 (actual) (ClinicalTrials.gov record NCT01213173, source copy `cardio:ctgov-nct01213173-2014-09-05`, retrieved 2026-11-18)
- Completion: 2011-09 (actual) (ClinicalTrials.gov record NCT01213173, source copy `cardio:ctgov-nct01213173-2014-09-05`, retrieved 2026-11-18)
- Results first posted: 2013-08-26 (ClinicalTrials.gov record NCT01213173, source copy `cardio:ctgov-nct01213173-2014-09-05`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT01213173, source copy `cardio:ctgov-nct01213173-2014-09-05`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01213173-2014-09-05`, retrieved 2026-11-18)

## The registry's words

- Brief title: Evaluation of Succinate Metoprolol on Heart Rate in the Stable Angina Patients
- Condition: Angina Pectoris
- Intervention (Drug): Succinate Metoprolol (Betaloc ZOK®)
- Intervention (Drug): Succinate Metoprolol (Betaloc ZOK®)
- Lead sponsor: AstraZeneca
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)
- Registry lists this organization as the lead sponsor: AstraZeneca (`cardio:astrazeneca`)

## Provenance

Content hash: 56bbfc275d2ef7a570c582ce29f43fca3951b29fd1dfb6e8eb4baabe6bbeb655
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
